Preclinical pharmacology and antitumour activity of the novel sequence-selective DNA minor-groove cross-linking agent DSB-120.
Walton, M I
Preclinical pharmacology and antitumour activity of the novel sequence-selective DNA minor-groove cross-linking agent DSB-120. [electronic resource] - Cancer chemotherapy and pharmacology 1996 - 431-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0344-5704
10.1007/s002800050507 doi
Animals
Antineoplastic Agents--chemistry
Benzodiazepinones--chemistry
Cell Survival--drug effects
Chromatography, High Pressure Liquid
Cisplatin--pharmacology
Colonic Neoplasms--drug therapy
Doxorubicin--pharmacology
Drug Stability
Female
Leukemia L1210--drug therapy
Male
Mice
Mice, Inbred BALB C
Plasmacytoma--drug therapy
Protein Binding
Tumor Cells, Cultured--drug effects
Preclinical pharmacology and antitumour activity of the novel sequence-selective DNA minor-groove cross-linking agent DSB-120. [electronic resource] - Cancer chemotherapy and pharmacology 1996 - 431-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0344-5704
10.1007/s002800050507 doi
Animals
Antineoplastic Agents--chemistry
Benzodiazepinones--chemistry
Cell Survival--drug effects
Chromatography, High Pressure Liquid
Cisplatin--pharmacology
Colonic Neoplasms--drug therapy
Doxorubicin--pharmacology
Drug Stability
Female
Leukemia L1210--drug therapy
Male
Mice
Mice, Inbred BALB C
Plasmacytoma--drug therapy
Protein Binding
Tumor Cells, Cultured--drug effects